(SREN) Swiss Re - Ratings and Ratios

Swiss Re AG, one of the worlds leading reinsurers, provides a comprehensive suite of risk transfer solutions, including wholesale reinsurance, insurance, and related services globally. The company operates through three specialized segments: Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. Each segment is tailored to address distinct market needs, leveraging Swiss Res extensive expertise in risk assessment and management. The company serves a diverse client base, including insurance companies, governmental entities, corporations, and individuals. Headquartered in Zurich, Switzerland, Swiss Re has a rich history dating back to its founding in 1863, and it is renowned for its innovative approach and commitment to sustainability.

The Property & Casualty Reinsurance segment offers a broad range of solutions, including property, liability, engineering, aviation, marine, and agricultural reinsurance. The Life & Health Reinsurance segment focuses on underwriting life and health insurance products, providing coverage for mortality, morbidity, and disability risks. The Corporate Solutions segment delivers tailored risk management solutions, including standard covers and multi-line programs, to mid-sized and large corporations. Swiss Res global presence, coupled with its advanced data analytics capabilities, enables it to provide cutting-edge risk management solutions to its clients worldwide.

Based on the provided data, Swiss Res stock (SREN) is currently trading at 141.80 CHF, with a 20-day average volume of 1,090,794 shares. The stock has shown upward momentum, with the last price exceeding the 20-day (139.21) and 50-day (138.38) simple moving averages (SMAs). The 200-day SMA of 120.64 indicates a longer-term bullish trend. The Average True Range (ATR) of 4.31 suggests moderate volatility, with potential price fluctuations of approximately 3-4% over the next three months.

Fundamentally, Swiss Res market capitalization stands at 41,214.05M CHF, with a price-to-earnings (P/E) ratio of 15.89 and a forward P/E of 12.22, indicating expectations of improved earnings. The price-to-book (P/B) ratio of 2.17 reflects a premium valuation relative to book value, while the price-to-sales (P/S) ratio of 0.93 highlights efficient revenue generation. The return on equity (RoE) of 15.27% underscores the companys strong profitability.

3-Month Forecast: Given the stocks current trajectory, Swiss Re is likely to maintain its bullish momentum, with a potential target price of 147-148 CHF over the next three months. Support levels are expected to hold around the 50-day SMA of 138.38 and the 200-day SMA of 120.64. The ATR of 4.31 suggests that price fluctuations will remain manageable, with a possible upside of 4-5% from current levels. The forward P/E of 12.22 and improving fundamental metrics further support a positive outlook for the stock.